ABIGAYLE COLON: Open Payments
NPI 1629698485 · RUSSELL SPRINGS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 62 payments from 8 companies in 2025. Trend: 2023 $30 · 2024 $274 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $318 |
| Alkermes, Inc. | 13 | $188 |
| AstraZeneca Pharmaceuticals LP | 3 | $146 |
| Vanda Pharmaceuticals Inc. | 5 | $94 |
| Averitas Pharma Inc. | 2 | $39 |
| Amgen Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: LYBALVI, AIRSUPRA, QULIPTA, VRAYLAR, FANAPT, UBRELVY, ARISTADA, QUTENZA.
Industry payments across KY — which companies pay providers there.
